
Pfizer Inc. said Thursday that its booster shot raised levels of neutralizing antibodies against both the original coronavirus strain and the Omicron variant in children aged 5 to 11. They said in a statement that they would ask the U.S. Food and Drug Administration to approve the emergency use of a booster for this age… read on > read on >